Your browser doesn't support javascript.
loading
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Ho, Kung-Chu; Fang, Yu-Hua Dean; Chung, Hsiao-Wen; Liu, Yuan-Chang; Chang, John Wen-Cheng; Hou, Ming-Mo; Yang, Cheng-Ta; Cheng, Nai-Ming; Su, Tzu-Pei; Yen, Tzu-Chen.
Afiliación
  • Ho KC; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
  • Fang YD; Department of Nuclear Medicine and Center for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital and Chang Gung University, 5 Fu-Shin Street, Kueishan, Taoyuan, 333, Taiwan.
  • Chung HW; Department of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan.
  • Liu YC; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
  • Chang JW; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Hou MM; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Yang CT; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Cheng NM; Department of Thoracic Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Su TP; Department of Nuclear Medicine and Center for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital and Chang Gung University, 5 Fu-Shin Street, Kueishan, Taoyuan, 333, Taiwan.
  • Yen TC; Department of Nuclear Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.
Eur J Nucl Med Mol Imaging ; 43(12): 2155-2165, 2016 Nov.
Article en En | MEDLINE | ID: mdl-27260520
Asunto(s)
Palabras clave
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Criterios de Evaluación de Respuesta en Tumores Sólidos / Clorhidrato de Erlotinib / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2016 Tipo del documento: Article
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Criterios de Evaluación de Respuesta en Tumores Sólidos / Clorhidrato de Erlotinib / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2016 Tipo del documento: Article